{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:32:12Z","timestamp":1794047532183,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.drugalcdep.2015.08.013","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T18:09:35Z","timestamp":1440526175000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"156","author":[{"given":"Aimee L.","family":"McRae-Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese K.","family":"Killeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen T.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Lindsay","family":"DeVane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0005","series-title":"Psychiatric Disorders in America","first-page":"116","article-title":"Syndromes of drug abuse and dependence","author":"Anthony","year":"1991"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1037\/1064-1297.2.3.244","article-title":"Comparative epidemiology of dependence on tobacco, controlled substances, and inhalants: basic findings from the National Comorbidity Study","volume":"2","author":"Anthony","year":"1994","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0260","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jpsychires.2007.05.004","article-title":"Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides","volume":"42","author":"Boldrini","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0015","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.addbeh.2007.04.004","article-title":"Marijuana use and social anxiety among marijuana using young adults","volume":"32","author":"Buckner","year":"2007","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.psychres.2009.10.010","article-title":"Effect of anxiety on treatment presentation and outcome: results from the Marijuana Treatment Project","volume":"178","author":"Buckner","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0025","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1360-0443.1999.94913114.x","article-title":"Marijuana withdrawal among adults seeking treatment for marijuana dependence","volume":"94","author":"Budney","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/10550490802408936","article-title":"A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence","volume":"18","author":"Carpenter","year":"2009","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugalcdep.2004.02.007","article-title":"Choosing a behavioral therapy platform for pharmacotherapy of substance users","volume":"75","author":"Carroll","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsat.2004.07.003","article-title":"Services research on adolescent drug treatment. Commentary on \u201cThe Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials\u201d","volume":"27","author":"Compton","year":"2004","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0091-3057(03)00150-3","article-title":"Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover","volume":"75","author":"Darmani","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drugalcdep.2008.04.013","article-title":"Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses","volume":"98","author":"David","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0055","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.nucmedbio.2007.06.008","article-title":"Serotonin-1A receptor imaging in recurrent depression: replication and literature review","volume":"34","author":"Drevets","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/j.1875-9114.1997.tb03059.x","article-title":"Clinical issues associated with urine testing of substances of abuse","volume":"17","author":"Eskridge","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0091-3057(90)90044-I","article-title":"The actions of diazepam and serotonergic anxiolytics vary according to the gender and the estrous cycle phase","volume":"37","author":"Fernandez-Guasti","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0166-4328(97)00047-8","article-title":"Anxiolytic actions of diazepam, but not of buspirone, are influenced by gender and the endocrine stage","volume":"88","author":"Fernandez-Guasti","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0075","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I\/P)","author":"First","year":"2002"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2165\/00003495-198632020-00002","article-title":"Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic","volume":"32","author":"Goa","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0085","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2036-z","article-title":"The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors","volume":"213","author":"Gomes","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ajp.2012.12010055","article-title":"A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents","volume":"169","author":"Gray","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jsat.2010.08.010","article-title":"Buproprion SR and contingency management for adolescent smoking cessation","volume":"40","author":"Gray","year":"2011","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0100","first-page":"50","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2008.12.010","article-title":"Reliability and validity of a short form of the Marijuana Craving Questionnaire","volume":"102","author":"Heishman","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S1461145705005651","article-title":"Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment","volume":"9","author":"Hill","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/jat\/22.6.445","article-title":"Differentiating new marijuana use from residual drug excretion in occasional marijuana users","volume":"22","author":"Huestis","year":"1998","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0120","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.neuroimage.2007.10.016","article-title":"Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET","volume":"39","author":"Jovanovic","year":"2008","journal-title":"NeuroImage"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0125","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.addbeh.2006.08.009","article-title":"Abstinence rates following behavioral treatments for marijuana dependence","volume":"32","author":"Kadden","year":"2007","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/S0007125000296244","article-title":"Can buspirone induce rebound, dependence or abuse?","volume":"12","author":"Lader","year":"1991","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0135","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neuropharm.2008.06.046","article-title":"Transcriptional regulation at a HTR1A polymorphism associated with mental illness","volume":"55","author":"Le Francois","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0140","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1523\/JNEUROSCI.23-25-08788.2003","article-title":"Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide","volume":"23","author":"Lemonde","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2010.12.010","article-title":"Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial","volume":"116","author":"Levin","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0150","first-page":"1","article-title":"Pharmacotherapies for cannabis dependence","volume":"12","author":"Marshall","year":"2014","journal-title":"Cochrane Database System. Rev."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0155","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/npp.2012.14","article-title":"A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults","volume":"37","author":"Mason","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0160","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/mol.109.060079","article-title":"Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine 1A receptor-dependent mechanisms","volume":"77","author":"Mato","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0165","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0740-5472(03)00041-2","article-title":"Treatment of marijuana dependence: a review of the literature","volume":"24","author":"McRae","year":"2003","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.drugalcdep.2009.06.022","article-title":"A placebo-controlled trial of buspirone for the treatment of marijuana dependence","volume":"105","author":"McRae-Clark","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1521-0391.2010.00076.x","article-title":"A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder","volume":"19","author":"McRae-Clark","year":"2010","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002109900147","article-title":"Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors","volume":"361","author":"Nakazi","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/10550490701525665","article-title":"Treatment of cannabis use disorders: a review of the literature","volume":"16","author":"Nordstrom","year":"2007","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0190","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.0006-341X.2001.00120.x","article-title":"Akaike's information criterion in generalized estimating equations","volume":"57","author":"Pan","year":"2001","journal-title":"Biometrics"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archpsyc.63.2.219","article-title":"Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population","volume":"63","author":"Poling","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0200","series-title":"National Household Survey on Drug Use and Health","author":"SAMHSA","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2007.11.004","article-title":"Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform","volume":"94","author":"Schmitz","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0210","series-title":"Measuring Alcohol Consumption: Psychological And Biological Methods","first-page":"41","article-title":"Timeline follow-back: a technique for assessing self-reported ethanol consumption","author":"Sobell","year":"1992"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0215","series-title":"Brief Counseling for Marijuana Dependence: A Manual for Treating Adults (Vol. HHS Publication No. (SMA) 12-4211)","author":"Steinberg","year":"2005"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0220","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1017\/S0033291706008361","article-title":"Cannabis use disorders in the USA: prevalence, correlates and co-morbidity","volume":"36","author":"Stinson","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.15288\/jsas.1994.s12.70","article-title":"Ensuring balanced distribution of prognostic factors in treatment outcome research","volume":"12","author":"Stout","year":"1994","journal-title":"J. Stud. Alcohol Suppl."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0230","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2165\/00023210-200923070-00001","article-title":"Pharmacotherapy for cannabis dependence: how close are we?","volume":"23","author":"Vandrey","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/00952990.2013.819362","article-title":"Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study","volume":"40","author":"Weinstein","year":"2014","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0240","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4088\/JCP.13m08862","article-title":"Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence","volume":"75","author":"Winhusen","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0245","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0250","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"key":"10.1016\/j.drugalcdep.2015.08.013_bib0255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1037\/a0014961","article-title":"Relations between anxiety sensitivity, distress tolerance, and fear reactivity to bodily sensations to coping and conformity use motives among young adult marijuana users","volume":"17","author":"Zvolensky","year":"2009","journal-title":"Exp. Clin. Psychopharmacol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615016063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615016063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T14:56:56Z","timestamp":1718031416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871615016063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":52,"alternative-id":["S0376871615016063"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.08.013","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}